- In January 2024, Sharps Technology signed a Letter of Intent (LOI) with Roncadelle Operations to expand the global sales and distribution of its safe drug delivery systems. The partnership aims to leverage Roncadelle’s extensive network to introduce Sharps' safety syringe technologies to markets in Europe, the Middle East, Africa, and Asia-Pacific. This collaboration will enhance the reach of Sharps' Securegard and Sologard products, offering healthcare providers safer and more efficient drug delivery solutions, and addressing the increasing global demand for advanced injection systems
- In April 2022, Thermo Fisher Scientific's PPD clinical research division partnered with Matrix Clinical Trials to enhance decentralized clinical trial solutions. This collaboration introduces mobile research sites and a virtual investigator network across the U.S., aiming to increase patient diversity and improve access to clinical trials. By reducing the need for patients to travel to traditional sites, the initiative seeks to enhance patient experience and engagement. The impact on the market includes broader geographic reach, improved data quality, and faster development timelines, aligning with the growing demand for patient-centric trial participation
- In March 2022, Colgate introduced its innovative Elixir toothpaste in Canada, following its European launch the previous spring. The product features a clear, recyclable PET tube with LiquiGlide’s EveryDrop coating, enabling users to easily dispense nearly every drop of toothpaste. This advancement enhances user convenience and reduces product waste, aligning with Colgate's commitment to sustainability. The Elixir line is available in select retailers and online platforms in Canada, marking a significant step in Colgate's global expansion of eco-friendly oral care products
